文献速递儿童感染儿童消化与营养

轮状病毒疫苗接种与5岁以下儿童轮状病毒腹泻全球负担

Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years.
PubMed 文献 · JAMA Pediatr · 2018-01-01

IMPORTANCE: Rotavirus infection is the global leading cause of diarrhea-associated morbidity and mortality among children younger than 5 years.…

要点

  • 2016年全球5岁以下儿童轮状病毒感染导致约128 500例死亡,其中撒哈拉以南非洲104 733例。
  • 疫苗使用估计避免了超过28 000例死亡,扩大使用尤其撒哈拉以南非洲可预防约20%腹泻相关死亡。

核心结论

  • 轮状病毒相关死亡率随时间显著下降,部分归因于轮状病毒疫苗的引入。

研究设计与样本

  • 本报告基于2016年全球疾病负担研究,为横断面研究,测量腹泻疾病及其病原体。
  • 使用模型估算数据稀疏地区的疾病负担。

主要发现

  • 2016年全球5岁以下儿童轮状病毒感染导致约128 500例死亡(95%不确定性区间104 500-155 600)。
  • 其中撒哈拉以南非洲死亡104 733例(95%不确定性区间83 406-128 842)。
  • 疫苗使用估计避免了超过28 000例死亡(95%不确定性区间14 600-46 700)。
  • 扩大轮状病毒疫苗使用尤其撒哈拉以南非洲可预防约20%的5岁以下儿童腹泻相关死亡。

临床怎么用

  • 应优先在撒哈拉以南非洲等地区引入轮状病毒疫苗并采取干预措施以减少腹泻相关发病和死亡。
  • 持续降低轮状病毒感染需全球范围内优先推广疫苗和干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Rotavirus infection is the global leading cause of diarrhea-associated morbidity and mortality among children younger than 5 years. OBJECTIVES: To examine the extent of rotavirus infection among children younger than 5 years by country and the number of deaths averted because of the rotavirus vaccine. DESIGN, SETTING, AND PARTICIPANTS: This report builds on findings from the Global Burden of Disease Study 2016, a cross-sectional study that measured diarrheal diseases and their etiologic agents. Models were used to estimate burden in data-sparse locations. EXPOSURE: Diarrhea due to rotavirus infection. MAIN OUTCOMES AND MEASURES: Rotavirus-associated mortality and morbidity by country and year and averted deaths attributable to the rotavirus vaccine by country. RESULTS: Rotavirus infection was responsible for an estimated 128 500 deaths (95% uncertainty interval [UI], 104 500-155 600) among children younger than 5 years throughout the world in 2016, with 104 733 deaths occurring in sub-Saharan Africa (95% UI, 83 406-128 842). Rotavirus infection was responsible for more than 258 million episodes of diarrhea among children younger than 5 years in 2016 (95% UI, 193 million to 341 million), an incidence of 0.42 cases per child-year (95% UI, 0.30-0.53). Vaccine use is estimated to have averted more than 28 000 deaths (95% UI, 14 600-46 700) among children younger than 5 years, and expanded use of the rotavirus vaccine, particularly in sub-Saharan Africa, could have prevented approximately 20% of all deaths attributable to diarrhea among children younger than 5 years. CONCLUSIONS AND RELEVANCE: Rotavirus-associated mortality has decreased markedly over time in part because of the introduction of the rotavirus vaccine. This study suggests that prioritizing vaccine introduction and interventions to reduce diarrhea-associated morbidity and mortality is necessary in the continued global reduction of rotavirus infection.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Troeger C, Khalil IA, Rao PC, et al. Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years. JAMA Pediatr. 2018. PMID: 30105384. doi:10.1001/jamapediatrics.2018.1960

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。